{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:22:46Z","timestamp":1787682166250,"version":"build-2784847793"},"reference-count":35,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["KNW-1-037\/K\/9\/O"],"award-info":[{"award-number":["KNW-1-037\/K\/9\/O"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Melanoma, the most dangerous type of cutaneous neoplasia, contributes to about 75% of all skin cancer-related deaths. Thus, searching for new melanoma treatment options is an important field of study. The current study was designed to assess whether the condition of mild and low-dose UVA radiation augments the lomefloxacin-mediated cytotoxic, growth-inhibitory and pro-apoptotic effect of the drug in melanoma cancer cells through excessive oxidative stress generation. C32 amelanotic and COLO829 melanotic (BRAF-mutant) melanoma cell lines were used as an experimental model system. The combined exposure of cells to both lomefloxacin and UVA irradiation caused higher alterations of redox signalling pathways, as shown by intracellular reactive oxygen species overproduction and endogenous glutathione depletion when compared to non-irradiated but lomefloxacin-treated melanoma cells. The obtained results also showed that lomefloxacin decreased both C32 and COLO829 cells\u2019 viability in a concentration-dependent manner. This effect significantly intensified when melanoma cells were exposed to UVA irradiation and the drug. For melanoma cells exposed to lomefloxacin or lomefloxacin co-treatment with UVA irradiation, the concentrations of the drug that decreased the cells\u2019 viability by 50% (EC50) were found to be 0.97, 0.17, 1.01, 0.18 mM, respectively. Moreover, we found that the redox imbalance, mitochondrial membrane potential breakdown, induction of DNA fragmentation, and changes in the melanoma cells\u2019 cell cycle distribution (including G2\/M, S as well as Sub-G1-phase blockade) were lomefloxacin in a dose-dependent manner and were significantly augmented by UVA radiation. This is the first experimental work that assesses the impact of excessive reactive oxygen species generation upon UVA radiation exposure on lomefloxacin-mediated cytotoxic, growth-inhibitory and pro-apoptotic effects towards human melanoma cells, indicating the possibility of the usage of this drug in the photochemotherapy of malignant melanoma as an innovative medical treatment option which could improve the effectiveness of therapy. The obtained results also revealed that the redox imbalance intensification mediated by the phototoxic potential of fluoroquinolones may be considered as a more efficient treatment model of malignant melanoma and may constitute the basis for the development of new compounds with a high ability to excessive oxidative stress generation upon UVA radiation in cancer cells.<\/jats:p>","DOI":"10.3390\/ijms21238937","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T08:59:15Z","timestamp":1606294755000},"page":"8937","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["UVA Radiation Enhances Lomefloxacin-Mediated Cytotoxic, Growth-Inhibitory and Pro-Apoptotic Effect in Human Melanoma Cells through Excessive Reactive Oxygen Species Generation"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2247-3004","authenticated-orcid":false,"given":"Artur","family":"Beberok","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7892-0462","authenticated-orcid":false,"given":"Zuzanna","family":"Rzepka","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8260-4339","authenticated-orcid":false,"given":"Jakub","family":"Rok","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Banach","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6918-3330","authenticated-orcid":false,"given":"Dorota","family":"Wrze\u015bniok","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"ref_1","first-page":"572","article-title":"Survival rates of patients with metastatic malignant melanoma","volume":"7","author":"Sandru","year":"2014","journal-title":"J. Med. Life"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/jid.2014.319","article-title":"Pro-survival role of MITF in melanoma","volume":"135","author":"Hartman","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/jid.2014.161","article-title":"UV signaling pathways within the skin","volume":"134","author":"Chen","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-4632.2011.05066.x","article-title":"Amelanotic melanomas presenting as red skin lesions: A diagnostic challenge with potentially lethal consequences","volume":"51","author":"McClain","year":"2012","journal-title":"Int. J. Dermatol."},{"key":"ref_5","first-page":"467","article-title":"Dermatoscopy of amelanotic and hypomelanotic melanoma","volume":"12","author":"Kittler","year":"2014","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1253735","article-title":"The melanoma revolution: From UV carcinogenesis to a new era in therapeutics","volume":"346","author":"Lo","year":"2014","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/jid.2015.14","article-title":"Targeted therapies in melanoma: Translational research at its finest","volume":"135","author":"Ho","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1086\/428055","article-title":"Antimicrobial safety: Focus on fluoroquinolones","volume":"41","author":"Owens","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.bmc.2019.05.038","article-title":"Fluoroquinolones structural and medicinal developments (2013\u20132018): Where are we now?","volume":"27","author":"Suaifan","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopha.2018.12.119","article-title":"Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth","volume":"111","author":"Yadav","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Beberok, A., Wrze\u015bniok, D., Szlachta, M., Rok, J., Rzepka, Z., Respondek, M., and Buszman, E. (2017). Lomefloxacin induces oxidative stress and apoptosis in COLO829 melanoma cells. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102194"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1442-9071.2007.01552.x","article-title":"Ocular toxicity of fluoroquinolones","volume":"35","author":"Thompson","year":"2007","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jphotobiol.2004.11.014","article-title":"Evaluation of phototoxic and photoallergic potentials of 13 compounds by different in vitro and in vivo methods","volume":"79","author":"Neumann","year":"2005","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1039\/b209220b","article-title":"Photophysics and photochemistry of fluoroquinolones","volume":"32","author":"Albini","year":"2003","journal-title":"Chem. Soc. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/chem.200701099","article-title":"Modeling the photochemistry of the reference phototoxic drug lomefloxacin by steady-state and time-resolved experiments, and DFT and post-HF calculations","volume":"14","author":"Freccero","year":"2008","journal-title":"Chemistry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1011-1344(98)00160-2","article-title":"Photocleavage of DNA by the fluoroquinolone antibacterials","volume":"45","author":"Martinez","year":"1998","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbabio.2011.03.010","article-title":"Recent advances in apoptosis, mitochondria and drug resistance in cancer cells","volume":"1807","author":"Indran","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.18632\/oncotarget.3131","article-title":"Inhibition of PI3K\/AKT\/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells","volume":"6","author":"Hambright","year":"2015","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jid.2016.06.625","article-title":"Reactive oxygen species dictate the apoptotic response of melanoma cells to TH588","volume":"136","author":"Wang","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijpharm.2016.06.009","article-title":"Berberine as a photosensitizing agent for antitumoral photodynamic therapy: Insights into its association to low density lipoproteins","volume":"510","author":"Andreazza","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molonc.2015.08.003","article-title":"Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells","volume":"10","author":"Baenke","year":"2016","journal-title":"Mol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e2253","DOI":"10.1038\/cddis.2016.105","article-title":"ROS homeostasis and metabolism: A dangerous liason in cancer cells","volume":"7","author":"Panieri","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"104884","DOI":"10.1016\/j.tiv.2020.104884","article-title":"The role of MITF and Mcl-1 proteins in the antiproliferative and proapoptotic effect of ciprofloxacin in amelanotic melanoma cells: In silico and in vitro study","volume":"66","author":"Beberok","year":"2020","journal-title":"Toxicol. In Vitro"},{"key":"ref_24","first-page":"6407","article-title":"Photodynamically-induced apoptosis due to ultraviolet A in the presence of lomefloxacin in human promyelocytic leukemia cells","volume":"37","author":"Nakai","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/10715760802317663","article-title":"Glutathione and apoptosis","volume":"42","author":"Circu","year":"2008","journal-title":"Free Radic. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbamcr.2005.12.012","article-title":"GSH depletion, protein S-glutathionylation and mitochondrial transmembrane potential hyperpolarization are early events in initiation of cell death induced by a mixture of isothiazolinones in HL60 cells","volume":"1763","author":"Frosali","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"29542","DOI":"10.1074\/jbc.M602500200","article-title":"SLCO\/OATP-like transport of glutathione in FasL-induced apoptosis: Glutathione efflux is coupled to an organic anion exchange and is necessary for the progression of the execution phase of apoptosis","volume":"281","author":"Franco","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14337","DOI":"10.1074\/jbc.M611019200","article-title":"Glutathione export during apoptosis requires functional multidrug resistance-associated proteins","volume":"282","author":"Hammond","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3390\/cancers3011285","article-title":"Glutathione in cancer cell death","volume":"3","author":"Ortega","year":"2011","journal-title":"Cancers"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Pfeffer, C.M., and Singh, T.K. (2018). Apoptosis: A target for anticancer therapy. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020448"},{"key":"ref_31","first-page":"4","article-title":"Regulation of DNA replication by the S-phase DNA damage checkpoint","volume":"3","author":"Willis","year":"2009","journal-title":"Cell Div."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tiv.2018.12.002","article-title":"Moxifloxacin as an inducer of apoptosis in melanoma cells: A study at the cellular and molecular level","volume":"55","author":"Beberok","year":"2019","journal-title":"Toxicol. In Vitro"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Rzepka, Z., Rok, J., Respondek, M., Pawlik, J., Beberok, A., Gryko, D., and Wrze\u015bniok, D. (2019). Cobalamin deficiency: Effect on homeostasis of cultured human astrocytes. Cells, 8.","DOI":"10.3390\/cells8121505"},{"key":"ref_34","first-page":"1727","article-title":"Ciprofloxacin triggers apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53\/Bax\/Bcl-2 signaling pathway","volume":"52","author":"Beberok","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2018.08.002","article-title":"GSH depletion, mitochondrial membrane breakdown, caspase-3\/7 activation and DNA fragmentation in U87MG glioblastoma cells: New insight into the mechanism of cytotoxicity induced by fluoroquinolones","volume":"835","author":"Beberok","year":"2018","journal-title":"Eur. J. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/23\/8937\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:37:07Z","timestamp":1760179027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/23\/8937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":35,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ijms21238937"],"URL":"https:\/\/doi.org\/10.3390\/ijms21238937","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]}}}